Valuation : Codexis, Inc.

Market Cap 165M 143M 134M 122M 229M 15.62B 231M 1.59B 617M 7.99B 621M 607M 26.23B P/E 2026 *
-4.06x
P/E 2027 * -5.28x
Enterprise Value 165M 143M 134M 122M 229M 15.62B 231M 1.59B 617M 7.99B 621M 607M 26.23B EV / Sales 2026 *
2.23x
EV / Sales 2027 * 1.87x
Free-Float
92.88%
Yield 2026 *
-
Yield 2027 * -
1 day-2.32%
1 week-10.61%
Current month-13.24%
1 month+1.72%
3 months-45.17%
6 months+44.61%
Current year-9.51%
1 week 1.47
Extreme 1.47
1.72
1 month 1.4
Extreme 1.395
1.76
Current year 0.96
Extreme 0.9583
2.98
1 year 0.96
Extreme 0.9583
2.98
3 years 0.96
Extreme 0.9583
6.08
5 years 0.96
Extreme 0.9583
42.01
10 years 0.96
Extreme 0.9583
42.01
Manager TitleAgeSince
Chief Executive Officer 59 07/11/2025
Director of Finance/CFO 59 30/09/2024
Chief Tech/Sci/R&D Officer 56 05/05/2020
Director TitleAgeSince
Director/Board Member 66 01/03/2016
Director/Board Member 59 07/11/2025
Chairman 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
23/02/26 Free

Chief Financial Officer

316,100 0.3500%
23/02/26 Sell

Chief Technology Officer

321,962 0.3565%
23/02/26 Free

Chief Executive Officer

993,000 1.0994%
Change 5-day change 1-year change 3-year change Capi.($)
-2.32%-10.61%-41.24%-18.06% 165M
+0.97%-1.75%+2.17%+18.46% 49.74B
-0.30%-2.88%+429.29%+521.04% 44.98B
+2.13%+0.89%+43.59%+19.44% 42.52B
+0.87%-3.73%+8.96%+76.62% 40.78B
-0.90%-1.74%+15.20%+48.44% 32.89B
+2.71%+6.82% - - 17.09B
+1.68%-4.20%+25.28%+123.70% 16.28B
+1.70%-1.75%+12.00%+28.50% 14.4B
+3.34%-1.13%+80.94%+42.82% 13.48B
Average +0.99%-1.94%+64.02%+95.66% 27.23B
Weighted average by Cap. +1.01%-2.25%+93.27%+128.89%

Financials

2026 *2027 *
Net sales 74.09M 63.91M 60.21M 54.86M 103M 7B 103M 713M 277M 3.58B 278M 272M 11.75B 88.44M 76.29M 71.87M 65.48M 122M 8.35B 123M 851M 330M 4.27B 332M 325M 14.03B
Net income -36.35M -31.36M -29.54M -26.92M -50.31M -3.43B -50.69M -350M -136M -1.76B -137M -134M -5.77B -28.54M -24.62M -23.2M -21.13M -39.5M -2.7B -39.8M -275M -107M -1.38B -107M -105M -4.53B
Net Debt - -
Logo Codexis, Inc.
Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Employees
146
Date Price Change Volume
03/09/26 $1.475 -2.32% 987,840
01/09/26 $1.510 -11.18% 1,067,725
31/08/26 $1.700 +6.92% 1,388,937
28/08/26 $1.590 -4.22% 634,645
27/08/26 $1.660 +0.61% 591,840
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1.510USD
Average target price
6.333USD
Spread / Average Target
+319.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CDXS Stock